CO-Releasing Molecules Have Nonheme Targets in Bacteria: Transcriptomic, Mathematical Modeling and Biochemical Analyses of CORM-3 [Ru(CO)3Cl(glycinate)] Actions on a Heme-Deficient Mutant of Escherichia coli.
CO-Releasing Molecules Have Nonheme Targets in Bacteria: Transcriptomic, Mathematical Modeling and Biochemical Analyses of CORM-3 [Ru(CO)3Cl(glycinate)] Actions on a Heme-Deficient Mutant of Escherichia coli.
复制标题
DOI:
10.1089/ars.2014.6151
复制
发表时间:
2015-07-10
影响因子:
6.6
通讯作者:
Poole RK
中科院分区:
文献类型:
--
作者:
Wilson JL;Wareham LK;McLean S;Begg R;Greaves S;Mann BE;Sanguinetti G;Poole RK
Aims: Carbon monoxide-releasing molecules (CORMs) are being developed with the ultimate goal of safely utilizing the therapeutic potential of CO clinically, including applications in antimicrobial therapy. Hemes are generally considered the prime targets of CO and CORMs, so we tested this hypothesis using heme-deficient bacteria, applying cellular, transcriptomic, and biochemical tools. Results: CORM-3 [Ru(CO)3Cl(glycinate)] readily penetrated Escherichia coli hemA bacteria and was inhibitory to these and Lactococcus lactis, even though they lack all detectable hemes. Transcriptomic analyses, coupled with mathematical modeling of transcription factor activities, revealed that the response to CORM-3 in hemA bacteria is multifaceted but characterized by markedly elevated expression of iron acquisition and utilization mechanisms, global stress responses, and zinc management processes. Cell membranes are disturbed by CORM-3. Innovation: This work has demonstrated for the first time that CORM-3 (and to a lesser extent its inactivated counterpart) has multiple cellular targets other than hemes. A full understanding of the actions of CORMs is vital to understand their toxic effects. Conclusion: This work has furthered our understanding of the key targets of CORM-3 in bacteria and raises the possibility that the widely reported antimicrobial effects cannot be attributed to classical biochemical targets of CO. This is a vital step in exploiting the potential, already demonstrated, for using optimized CORMs in antimicrobial therapy. Antioxid. Redox Signal. 23, 148–162.
登录
查看更多内容
DOI:
10.1073/pnas.95.18.10378
发表时间:
1998-09-01
影响因子:
11.1
作者:
Gardner, PR;Gardner, AM;Salzman, AL
通讯作者:
Salzman, AL
影响因子:
20.1
作者:
Clark, JE;Naughton, P;Motterlini, R
通讯作者:
Motterlini, R
影响因子:
9.9
作者:
通讯作者:
--
影响因子:
5.8
作者:
Asif, H. M. Shahzad;Rolfe, Matthew D.;Sanguinetti, Guido
通讯作者:
Sanguinetti, Guido
影响因子:
38.9
作者:
Foresti, Roberta;Bani-Hani, Mohamed G.;Motterlini, Roberto
通讯作者:
Motterlini, Roberto